ArticleInternational journal for equity in health2025
Mortality and barriers to healthcare among people experiencing homelessness in Paris: a mixed-methods study.
Article in International journal for equity in health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Experiences of Healthcare Professionals in a Street Clinic in a Municipality in Southern Brazil.International journal of environmental research and public health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHomelessness is a global problem with significant public health implications. Persons experiencing homelessness (PEH) face poorer health outcomes and elevated risks of premature death compared to the general population. This is also true for PEH in France, despite the country’s system of universal health coverage. This study investigates 10-year mortality patterns among PEH in Paris and barriers to accessing healthcare.
methodsDeaths among PEH—including demographic information and causes of death, identified through active case finding by volunteers—were compared to those in the general population of mainland France. Percentages were standardized for the sex distribution of the PEH population, using data from the National Institute of Statistics and Economic Studies and the Epidemiology Centre on Medical Causes of Death. We conducted semi-structured interviews with 11 healthcare and social service providers to explore barriers to healthcare access for PEH, using a pre-existing theoretical framework to guide interviews and analysis.
resultsBetween 2014 and 2023, 1 559 PEH (89.4% men) died in Paris. The median age of death was 54 years (IQR: 46–63), younger than the general population’s median of 80 years (IQR: 67–88). Notably, 1184 (75.9%) died before age 65, compared to 19.5% in the general population. Most deaths (450, 68.1%) were due to disease, with circulatory diseases (128, 19.4%) and neoplasms (102, 15.4%) as most common causes, similar to the general population. Barriers to healthcare access were manifold. Acceptability was low due to mismatches between provider attitudes and practices and the needs of PEH. Availability was limited due to capacity constraints and poor interdisciplinary collaboration. Geographical accessibility, when services were far from PEHs habitual locations, reinforced reluctance to health care use. Affordability and administrative hurdles impeded access for the uninsured.
conclusionPEH in Paris die from the same diseases as the general population, but at a much younger age, despite universal health coverage. The earlier onset of disease and multiple healthcare access barriers suggest an urgent need for improved social support and integrated care. Above all, the provision of stable, affordable housing could both mitigate the health impacts of homelessness and tackle its root causes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.